BMY vs CLH · P/E 17, rev $24.46B vs P/E 38, rev $6.03B
Bristol-Myers Squibb Company (BMY) versus Clean Harbors Inc (CLH) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US.
Clean Harbors Inc (CLH) is a waste management company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CLH revenue for 2025-12-31 was $6.03B. Net income was $391.0M. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. CLH currently screens at market cap $14.96B and trailing P/E 38.4.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CLH currently screens at market cap $14.96B and trailing P/E 38.4.
Not investment advice. Open the BMY and CLH stock pages for the full models.
Not investment advice.